{"url_path":"/sec/oncy/8-k/2026-07-20/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-20","source_url":"https://www.sec.gov/Archives/edgar/data/1129928/0001129928-26-000045-index.html","accession_number":"0001129928-26-000045","cik":"0001129928","ticker":"ONCY","issuer_name":"ONCOLYTICS BIOTECH INC","edgar_url":"https://www.sec.gov/Archives/edgar/data/1129928/0001129928-26-000045-index.html","primary_entity_key":"0001129928","primary_entity_name":"ONCOLYTICS BIOTECH INC"},"word_count":87,"has_tables":true,"body_markdown":"Item 9.01. Financial Statements and Exhibits.\n\n(d) Exhibits.\n\nExhibit No.\n\nDescription\n\n99.1\n\n[Press Release issued by Oncolytics Biotech Inc., dated as of J](oncolyticsscacfasttrack.htm)[u](oncolyticsscacfasttrack.htm)[l](oncolyticsscacfasttrack.htm)[y](oncolyticsscacfasttrack.htm)[20](oncolyticsscacfasttrack.htm)[, 2026](oncolyticsscacfasttrack.htm).\n\n104\n\nCover Page Interactive Data File (embedded within the Inline XBRL document).\n\nSIGNATURE\n\nPursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\nDate: July 20, 2026\n\nONCOLYTICS BIOTECH INC.\n\nBy:\n\n/s/ Kirk Look\n\nName:\n\nKirk Look\n\nTitle:\n\nChief Financial Officer"}